Acta Neurologica Scandinavica

Papers
(The TQCC of Acta Neurologica Scandinavica is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Issue Information70
Drug‐Induced Intracranial Pressure Increase: Disproportionality Analysis of the Public Version of the FDA Event Reporting System61
Awake Surgery for Tumors of the Parietal Lobe: A Preliminary Experience with a New Protocol of Intraoperative Neuropsychological Test for the Monitoring of the Sensory Area Function51
The Diagnostic Pathway for Intracranial Tumours: A 10‐Year North Denmark Region Cohort Study47
The prognosis of late‐onset anti‐N‐methyl‐D‐aspartate receptor encephalitis in China43
Validity and reliability characteristics of the Silhouettes Fatigue Scale in measuring multiple sclerosis‐related fatigue in Turkish‐speaking adults42
Clinical features and spectrum of NOTCH3 variants in Finnish patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoen37
Quality of life in patients with glioblastoma and their relatives32
Epileptic seizure control during and after pregnancy in Australian women32
Preoperative Short‐Term Efgartigimod Benefits Myasthenia Gravis Patients Undergoing Thymectomy32
Etiologies of Rapidly Progressive Dementia: A Cross‐Sectional Multicentric Tertiary Hospital Study29
Fatigue and Sleepiness in Multiple Sclerosis and Their Response to Short‐Term Treatment With Modafinil28
Hereditary Ataxias: A Genetic Epidemiological Study of a Danish Clinical Cohort28
Effects of fast‐velocity concentric resistance training in people with multiple sclerosis: A randomized controlled trial25
Blood based biomarkers for movement disorders25
Issue Information22
Tocilizumab for severe refractory primary central nervous system vasculitis: A center experience22
Cerebrospinal Fluid Metabolites Mediate the Impact of Gut Microbiota on Amyotrophic Lateral Sclerosis: Novel Insights From Mendelian Randomization20
Mental Fatigue After Aneurysmal Subarachnoid Hemorrhage: A Prospective 5‐Year Follow‐Up Study20
Real-Life Effectiveness and Tolerability of Brivaracetam in Focal to Bilateral and Primary Generalized Tonic-Clonic Seizures19
Risk Factors of Oropharyngeal Dysphagia and Malnutrition in Neurological Patients19
Patient factors associated with receiving reversal therapy in oral anticoagulant‐related intracerebral hemorrhage18
The Relationship between Motor Symptoms, Signs, and Parkinsonism with Facial Emotion Recognition Deficits in Individuals with 22q11.2 Deletion Syndrome at High Genetic Risk for Psychosis18
17
Volume and Visual Field Defects in Occipital Stroke: The NOR-OCCIP Study17
Early post‐traumatic seizures in hospitalized patients with traumatic brain injury17
A Predictive Model and Survival Analysis for Tube Feeding in ALS Patients: A Prospective Cohort Study in a Chinese ALS Clinic17
Prehospital triage optimization of patients with large vessel occlusion by Austrian Prehospital Stroke Scale17
Sarcopenia and Hypoxia in Patients with Obstructive Sleep Apnea16
Depression of Family Caregivers of Patients With Disorders of Consciousness: A Systematic Review16
Multiple Sclerosis and Suicide Attempts: A Review including a Meta-Analysis of Prevalence16
15
Natural history and remarkable psychiatric state of late‐onset amyotrophic lateral sclerosis in China15
Cover Image15
Motor Band Sign in Motor Neuron Diseases Using Magnetic Resonance Imaging: A Systematic Review15
Impulsivity in Male Episodic Cluster Headache14
Effect of Dual- versus Single-Antiplatelet Therapy on Early Neurological Deterioration in Minor Stroke of Undetermined Cause14
Changes in Retinal Thickness and Brain Volume during 6.8-Year Escalating Therapy for Multiple Sclerosis13
Epileptic Network Surgery: From Network Basis to Clinical Practice13
Perampanel Monotherapy for Focal and Generalized Epilepsy in Clinical Practice13
Clinical Insights Into Anti‐Sulfatide Antibodies in Peripheral Neuropathies: A Retrospective Study13
Prognosis and Outcome of Cerebral Sinus Venous Thrombosis—A Multicenter Cohort Study13
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines13
Eculizumab Versus Rituximab for Refractory Antiacetylcholine Receptor Antibody‐Positive Generalized Myasthenia Gravis: A Single‐Center Experience13
Lifestyle and complementary therapies in multiple sclerosis guidelines: Systematic review13
Is there a role for off‐label high‐efficacy disease‐modifying drugs in progressive multiple sclerosis? A network meta‐analysis12
Expression Patterns of miRNA in the Experimental Autoimmune Encephalomyelitis (EAE)/MS Model Treated With Oenothera biennis Oil12
Sleep stability in isolated rapid eye movement sleep behavior disorder, Parkinson's disease, and dementia with Lewy bodies12
Potential mechanism of SARS‐CoV ‐2‐associated central and peripheral nervous system impairment12
Comment on comorbidities in older patients with myasthenia gravis12
The Regulation of Plasma Interleukin-6 Levels Is Modified by Hippocampal Sclerosis and Its Lateralization in Drug-Resistant Temporal Lobe Epilepsy11
Blood biomarkers in epilepsy11
Evaluation of the Clinical and Prognostic Characteristics of Myasthenia Gravis Patients Followed Up in a Tertiary Neuromuscular Disease Center in Thrace Region of Turkey11
Diagnostic Panel of Three Genetic Biomarkers Based on Artificial Neural Network for Patients With Idiopathic Generalized Epilepsy10
Analysis of Factors Related to the Severity of Basal Ganglia Aphasia and Quality of Life in Patients With Postcerebral Hemorrhage10
Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study9
Altered Cerebellar Volumes and Intrinsic Cerebellar Network in Juvenile Myoclonic Epilepsy9
Special issue on blood biomarkers in neurology9
9
Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review9
Editorial9
8
Prehospital Clinical Presentations and Sex Differences in Stroke Cases and Mimics: A 1‐Year Study in a Stroke Unit8
Independent Predictors for Operative Treatment of Chronic Subdural Hematoma8
New‐Onset Refractory Status Epilepticus Caused by Autoimmune Encephalitis May Have a Better Prognosis than when due to Other Causes8
8
Small fiber neuropathy8
Corrigendum to “Eslicarbazepine Acetate Response in Intellectual Disability Population Versus General Population”8
Stroke thrombolysis – Is more better?7
Temporal trends of epilepsy in multiple sclerosis7
Neurological sequelae in acute carbon monoxide poisoning: A prospective observational study with MRI data7
Intravenous thrombolysis for acute ischemic stroke in COVID‐19 era: Still the same?7
High on‐treatment platelet reactivity is associated with poor outcomes after ischemic stroke: A meta‐analysis7
What Effects Can Expressive Writing Have on Sexual Dysfunction in Women with Multiple Sclerosis? A Randomized Controlled Trial7
Blood biomarkers of peripheral neuropathy7
Theory of mind: A clue for the interpretation of functional movement disorders7
Seizure detection based on wearable devices: A review of device, mechanism, and algorithm7
Pathophysiology of transient neurological deficit in patients with chronic subdural hematoma: A systematic review7
Relapse factors of patients of anti‐N‐methyl‐D‐aspartate receptor encephalitis6
Prehospital stroke scales—the need for a gold standard in the field6
Glymphatic dysfunction in isolated REM sleep behavior disorder6
Brain Injury Biomarkers in Humans Undergoing General Anaesthesia and Noncerebral Surgery6
Incidence of first‐ever transient ischemic attack in Eastern Finland6
Clinimetric study and review of the Reaction Level Scale6
Intra‐ or peri‐procedural rupture in the endovascular treatment of intracranial aneurysms6
Hands–feet wireless devices: Test–retest reliability and discriminant validity of motor measures in Parkinson's disease telemonitoring6
Association Between Initial Corticosteroid Regimen and Treatment Response Time in Acetylcholine Receptor Antibody–Positive Myasthenia Gravis6
Comparison and Validation of Diagnostic Criteria of Malignant Middle Cerebral Artery Infarction6
0.97810482978821